ArticleJournal of Cancer2020

Strategic Trastuzumab Mediated Crosslinking Driving Concomitant HER2 and HER3 Endocytosis and Degradation in Breast Cancer.

Jennifer Mary Wymant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.